do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline Mechanisms of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, glucagon‐like do not combine dpp-4 inhibitors
Description
Nor did its effects deteriorate over time (Zander, Madsbad, Madsen, Holst)
The first oral (pill) form of a GLP-1 (semaglutide, brand name Wegovy) became available in January 2026
Another key research frontier is understanding how GLP-1 RAs affect growth, puberty, and psychosocial development
8,9,31,32 These trials provided the first signs of the benefit of GLP-1RAs in HF
Polyagonists in type 2 diabetes management
